JETEMA, Co., Ltd. (KOSDAQ:216080)
South Korea · Delayed Price · Currency is KRW 5,810.00
+10.00 (0.17%)
Oct 31, 2025, 3:30 PM KST
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 208.34 billion as of October 31, 2025. Its market cap has decreased by -29.17% in one year.
Market Cap
208.34B
Enterprise Value
304.67B
Revenue
70.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,810.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 208.34B, an increase of 61.37%. That is a compound annual growth rate of 8.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 208.34B | -24.88% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | 402.27B | 139.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.90T |
| ALTEOGEN | 24.95T |
| SK Biopharmaceuticals | 8.97T |
| Yuhan | 8.77T |
| HLB Co., Ltd. | 6.30T |
| Peptron | 6.18T |
| PharmaResearch | 5.36T |